Huge drug cost disparities seen in health overhaul

by Ricardo Alonso-Zaldivar

(AP)—Consumer alert: If you or someone you know needs costly medications and you're hoping President Barack Obama's health care law will meet the need, you may be in for a surprise.

Where you live could make a huge difference in what you'll pay.

To keep premiums low, some states are allowing insurers to charge patients a large share of the cost for expensive medications for cancer and other serious conditions.

These "specialty drugs" cost thousands of dollars a month.

In California, the patient's share would be up to 30 percent. New York is doing it differently, setting flat copayments for all medications. The highest is $70.

Critics fear most states will follow California's lead.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Obama health law a good deal for states

Nov 26, 2012

(AP)—A new report says states can receive more than $9 in federal money for every dollar they spend to cover low-income residents under President Barack Obama's health care law.

Study: Health overhaul to raise claims cost 32 pct

Mar 26, 2013

(AP)—The nation's leading group of financial risk analysts says medical claims costs—the biggest driver of insurance premiums—will jump an average 32 percent for individual policies under President Barack Obama's health ...

Recommended for you

Experts want restrictions on testosterone drug use (Update)

6 hours ago

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

Big cities take aim at prescription painkillers

Sep 16, 2014

Some of the nation's largest cities are ratcheting up their criticism of prescription painkillers, blaming the industry for a wave of addiction and overdoses that have ravaged their communities and busted local budgets.

World Health Organization policy improves use of medicines

Sep 16, 2014

In this issue of PLOS Medicine, Kathleen Holloway from WHO and David Henry (University of Toronto, Canada) evaluated data on reported adherence to WHO essential medicines practices and measures of quality use of medicines from 5 ...

User comments